Skip to the main content

Original scientific paper

The level of interleukin-1after intravesical klh instillation in patients with superficial transitional cell cancer of the urinary bladder

Carlos Winkler
Karl Friedrich Klippel


Full text: english pdf 190 Kb

page 11-19

downloads: 284

cite

Full text: croatian pdf 190 Kb

page 11-19

downloads: 169

cite


Abstract

Our study confirms the theory that instillation of KLH stimulates production of cytokines, resulting in their secretion in urine. Interleukin- 1 (IL-1) stimulates the immune cascade through a domino effect and is produced mainly by activated macrophages. The instillation program was started 5-7 days after TUR of primary superficial cell carcinoma. Twenty mg KLH in 20 ml of 0.9%
NaCl was instilled into the bladder each week for 6 consecutive weeks and then monthly for one year. When KLH is instilled into the bladder, IL-1alpha is secreted in the urine. A specific enzyme-linked immunosorbent assay (ELISA) was used for analysis. The ELISA for IL-1a was established in our laboratory and showed a detection limit of 5 pg/ml. This IL-1a ELISA deviation amounts to 3-7% within a series of measurements, and 5-15% from series to series. In the therapy group the IL-1a secretion ranged from 0 to 30,905 pg/24 h and in the control group from 0 (collection period) to 2,472 pg/4 h. IL 1a production increased significantly after KLH instillation in bladder cancer patients; however, the level varied considerably from patient to patient. Maximum production was achieved within a period of 4-8 h, decreasing within 24 h. There was a striking difference between the amount of IL-1a produced over the 24-hour period in the control group and that of the KLH group. 8 of 14 patients (57%) who responded to KLH therapy, had higher urine IL-1a levels after 6 weeks of KLH treatment than those who failed to respond within 12 months, but the levels were not of statistical significance. The secretion of IL-1a in urine is the biological response of the bladder to the antigen stimulus of KLH. No IL-2 was detected in the urine samples. It remains to be determined whether no IL-2 cytokine was present, or whether the amount was smaller than the minimal detection limit required for the ELISA.

Keywords

Keyhole Limpet Hemocyanine; Interleukin 1α; Interleukin 2; Transitional cell carcinoma of the urinary bladder

Hrčak ID:

191044

URI

https://hrcak.srce.hr/191044

Publication date:

1.12.2006.

Article data in other languages: croatian

Visits: 1.302 *